Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer
- 8 May 2025
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 165, 107349
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (K08CA283306, P30 CA008748)
This publication has 33 references indexed in Scilit:
- A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinomaCancer, 2023
- Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk‐adapted adjuvant therapy for squamous cell carcinoma of the head and neckCancer, 2018
- Outcomes after free tissue transfer for composite oral cavity resections involving skinHead & Neck, 2018
- Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapyHead & Neck, 2016
- Factors in Successful Elimination of Elective Tracheotomy in Mandibular Reconstruction With Microvascular TissueJAMA Otolaryngology–Head & Neck Surgery, 2016
- Airway management after maxillectomy with free flap reconstructionHead & Neck, 2012
- Long-term Health-Related Quality of Life in Survivors of Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2012
- Long-term Quality of Life for Surgical and Nonsurgical Treatment of Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2005
- Diagnostic Accuracy of Magnetic Resonance Imaging in the Assessment of Mandibular Involvement in Oral-Oropharyngeal Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 2004
- Are head and neck specific quality of life measures necessary?Head & Neck, 1997